A lesser-known symptom of dementia could appear when someone walks, according to experts. This could not only alert you to a ...

Lewy body dementia is relatively unknown despite more than 100,000 Australians living with the diagnosis that affects ...

Little is known about a form of dementia that affects more than 100,000 Australians but researchers are looking to build ...

The following column was originally published May 28, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

Lewy body dementia, family dynamics, long-buried secrets and murder are the story threads woven through “Carolina Moonset,” the 2024 One Book, One Community selection for Hutchinson.

CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...

About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...

About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...

Cognition Therapeutics (CGTX) announced that JamesGalvin, MD, MPH will present topline results from the ‘SHIMMER’ study of zervimesine in ...

The initial topline results for the Phase 2b study of neflamapimod in dementia with Lewy bodies (DLB) were previously disclosed on December 10, 2024 and are available here. CervoMed Inc. is a clinical ...